greeksoup/ stock research

Johnson & Johnson (JNJ) FY2016 results: revenue $71.9 billion, up 2.6% on the year

Johnson & Johnson (JNJ) reported revenue of $71.9 billion for fiscal 2016, the year ended 1 January 2017, up 2.6% on the year before. Net income was $16.5 billion, up 7.3%, and diluted earnings per share $5.93. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2019.

Revenue
$71.9 billion
+2.6% on the year
FY2009FY2016
Operating margin
n/a
FY2009FY2016
Net income
$16.5 billion
+7.3% on the year
FY2009FY2016
Diluted EPS
$5.93
+8.2% on the year
FY2009FY2016

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2016FY2015FY2014On the yearLast 8 years
Revenue71,89070,07474,331+2.6%
Cost of revenue21,78921,53622,746+1.2%
Gross profit50,10148,53851,585+3.2%
Gross margin69.7%69.3%69.4%
Research and development9,1439,0468,494+1.1%
Selling, general and administrative20,06721,20321,954-5.4%
Operating incomen/an/a21,590
Operating marginn/an/a29.0%
Interest expense726552533+31.5%
Pre-tax income19,80319,19620,563+3.2%
Income tax3,2633,7874,240-13.8%
Effective tax rate16.5%19.7%20.6%
Net income16,54015,40916,323+7.3%
Net margin23.0%22.0%22.0%
Diluted EPS$5.93$5.48$5.70+8.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2016FY2015FY2014On the yearLast 8 years
Operating cash flow18,76719,56918,710-4.1%
Capital expenditure3,2263,4633,714-6.8%
Free cash flow15,54116,10614,996-3.5%
Free cash flow margin21.6%23.0%20.2%
Cash from investing-4,761-7,735-12,305
Cash from financing-8,551-11,136-12,499
Depreciation and amortisation3,7543,7463,895+0.2%
Share-based compensation878874792+0.5%
Buybacks8,9795,2907,124+69.7%
Dividends paid8,6218,1737,768+5.5%
Dividend per share$3.15$2.95$2.76+6.8%
Diluted shares, weighted2,789m2,813m2,864m-0.9%

Balance sheet

$ millionFY2016FY2015FY2014On the yearLast 8 years
Shareholders' equity70,41871,15069,752-1.0%
Debt27,12619,86118,760+36.6%
Other liabilities43,66442,40041,846+3.0%
Total liabilities and equity141,208133,411130,358+5.8%
Fixed assets15,91215,90516,126+0.0%
Goodwill22,80521,62921,832+5.4%
Intangible assets26,87625,76427,222+4.3%
Investments22,93524,64418,566-6.9%
Cash and equivalents18,97213,73214,523+38.2%
Receivables11,69910,73410,985+9.0%
Inventory8,1448,0538,184+1.1%
Other assets13,86512,95012,920+7.1%
Total assets141,208133,411130,358+5.8%

10-K for the year ended 1 January 2017, filed 20 February 2019: the filing.